Tower Research Capital (TRC)’s Galmed Pharmaceuticals GLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-59
Closed -$188 5422
2024
Q4
$188 Sell
59
-114
-66% -$363 ﹤0.01% 5391
2024
Q3
$1.19K Buy
+173
New +$1.19K ﹤0.01% 5193
2023
Q3
Sell
-4
Closed -$152 6034
2023
Q2
$152 Buy
+4
New +$152 ﹤0.01% 5746
2021
Q4
Sell
-10
Closed -$5K 6291
2021
Q3
$5K Buy
10
+3
+43% +$1.5K ﹤0.01% 4860
2021
Q2
$4K Sell
7
-7
-50% -$4K ﹤0.01% 4809
2021
Q1
$9K Sell
14
-32
-70% -$20.6K ﹤0.01% 4421
2020
Q4
$26K Sell
46
-10
-18% -$5.65K ﹤0.01% 3688
2020
Q3
$35K Buy
+56
New +$35K ﹤0.01% 3676
2020
Q2
Sell
-9
Closed -$5K 4830
2020
Q1
$5K Sell
9
-26
-74% -$14.4K ﹤0.01% 2293
2019
Q4
$37K Buy
+35
New +$37K ﹤0.01% 1521
2019
Q3
Sell
-29
Closed -$38K 4242
2019
Q2
$38K Buy
29
+26
+867% +$34.1K ﹤0.01% 1765
2019
Q1
$5K Buy
+3
New +$5K ﹤0.01% 3053
2018
Q4
Sell
-2
Closed -$5K 4013
2018
Q3
$5K Buy
+2
New +$5K ﹤0.01% 3114
2017
Q3
Sell
-1
Closed -$1K 3961
2017
Q2
$1K Buy
+1
New +$1K ﹤0.01% 2485
2016
Q4
Hold
0
4034
2016
Q3
Sell
-2
Closed -$1K 3925
2016
Q2
$1K Buy
+2
New +$1K ﹤0.01% 4151
2015
Q4
Sell
-1
Closed -$1K 4683
2015
Q3
$1K Buy
+1
New +$1K ﹤0.01% 3616
2015
Q2
Sell
-4
Closed -$6K 4620
2015
Q1
$6K Sell
4
-3
-43% -$4.5K ﹤0.01% 3140
2014
Q4
$8K Buy
+7
New +$8K ﹤0.01% 2335
2014
Q3
Sell
-11
Closed -$19K 4577
2014
Q2
$19K Buy
11
+4
+57% +$6.91K ﹤0.01% 1869
2014
Q1
$15K Buy
+7
New +$15K ﹤0.01% 2169